ASHG 2013 workshop: Complementing next generation sequencing experiments with high-resolution copy number variation detection

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative genetics research and biomarker solutions to advance molecular medicine.

The company has three core commercial arms: Genomics, Biomarkers and Licensing. In addition, an Exploratory Research division, headed by Professor Southern, focuses on developing new diagnostic techniques with potential for in-house commercialisation or partnering with diagnostic and pharmaceutical organisations.

With its clear strategic focus, OGT has invested significantly in highly qualified expertise, doubling the workforce over the last 2 years to over 60 people. In anticipation of this rapid expansion, OGT moved to a new, purpose-built facility located in the Begbroke Science Park near Oxford, UK. These strategic decisions have resulted in strong year-on-year revenue growth across all business units. The company plans further expansion fuelled by growth into the clinical research market, a full pipeline of new products and further corporate development opportunities.

OGT’s highly experienced management team are driving this growth through end-user sales and by forging strong relationships with major international corporations including Agilent, Illumina and Roche.